Non-invasive imaging could help match leukaemia patients with treatments
Researchers at the Francis Crick Institute have identified visual changes in the bone marrow caused by acute myeloid leukaemia (AML). The imaging technique used is now being tested in hospital to see if it could help predict whether different treatments will be effective in individual patients.
Published: 3 August 2021